- Works count
- 523
- Citation count
- 40,281
- H-index
- 79
- i10-index
- 228
Research interests
Publications
2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease: developed under the auspices of the ESC Clinical Practice Guidelines Committee
European Heart Journal · 2025 · https://doi.org/10.1093/eurheartj/ehaf191
Survival After Invasive or Conservative Management of Stable Coronary Disease
Circulation · 2022 · https://doi.org/10.1161/circulationaha.122.062714
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study
The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(21)00249-x
Initial Invasive or Conservative Strategy for Stable Coronary Disease
New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa1915922
Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque
Journal of the American College of Cardiology · 2020 · https://doi.org/10.1016/j.jacc.2020.09.547
Ticagrelor in Patients with Stable Coronary Disease and Diabetes
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1908077
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1911303
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial
Nephrology Dialysis Transplantation · 2019 · https://doi.org/10.1093/ndt/gfz290
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)31887-2
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)31887-2
Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
Journal of the American Heart Association · 2017 · https://doi.org/10.1161/jaha.116.005077
Physical Activity and Mortality in Patients With Stable Coronary Heart Disease
Journal of the American College of Cardiology · 2017 · https://doi.org/10.1016/j.jacc.2017.08.017
The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation
European Heart Journal · 2016 · https://doi.org/10.1093/eurheartj/ehw054
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1600176
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1600175
Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study
European Heart Journal · 2013 · https://doi.org/10.1093/eurheartj/eht188
Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial
Circulation · 2011 · https://doi.org/10.1161/circulationaha.111.047498
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1109719
Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial
European Heart Journal · 2011 · https://doi.org/10.1093/eurheartj/ehr422
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery
Journal of the American College of Cardiology · 2010 · https://doi.org/10.1016/j.jacc.2010.10.029
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
New England Journal of Medicine · 2009 · https://doi.org/10.1056/nejmoa0904327
Glucose Levels Predict Hospitalization for Congestive Heart Failure in Patients at High Cardiovascular Risk
Circulation · 2007 · https://doi.org/10.1161/circulationaha.106.661405
Current projects
No projects listed.